跳至主要内容
临床试验/NCT07145385
NCT07145385尚未招募不适用

Prevalence of Alpha-1 Antitrypsin Deficiency in a Cohort of Hepatocellular Carcinoma on Non-Cirrhotic Liver Without Identified Etiologies

University Hospital, Bordeaux1 个研究点 分布在 1 个国家目标入组 71 人开始时间: 2026年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
71
试验地点
1
主要终点
Prevalence of Alpha-1 Antitrypsin Deficiency

研究概览

简要总结

Patients with Alpha-1 Antitrypsin Deficiency (AATD), a rare genetic disease, have a 20- to 50-fold higher risk of developing primary liver cancer (PLC), such as hepatocellular carcinoma (HCC), in both cirrhotic and non-cirrhotic livers, highlighting AATD as a potential oncogenic factor. Therefore, our aim is to evaluate the association between AATD and HCC in patients with a non-cirrhotic liver and no known predisposition

详细描述

The two most common pathogenic AATD variants, PiS and PiZ, will be identified using the multiplex digital PCR (dPCR) system in a French cohort of 71 patients who developed HCC in a non-cirrhotic liver without known risk factors for HCC

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients (≥18 years of age).
  • •Histopathologically confirmed diagnosis of hepatocellular carcinoma (HCC).
  • •Normal liver or chronic liver disease with minimal to moderate fibrosis in non-tumoral tissue.
  • •Signed informed consent obtained prior to participation.
  • •No other known etiology or risk factors for liver disease, including:
  • •Alcohol-related liver disease
  • •Metabolic-associated steatohepatitis (MASH)
  • •Viral hepatitis infections
  • •Hemochromatosis

排除标准

  • •Minor patients (<18 years of age).
  • •HCC diagnosis not established according to standard histopathological criteria.
  • •Liver with chronic liver disease showing advanced fibrosis in non-tumoral tissue.
  • •No signed informed consent prior to participation.
  • •Presence of other identified etiologies or known risk factors for liver disease, including:
  • •Alcohol-related liver disease
  • •Metabolic-associated steatohepatitis (MASH)
  • •Viral hepatitis infections
  • •Hemochromatosi

结局指标

主要结局

Prevalence of Alpha-1 Antitrypsin Deficiency

时间窗: 1 year

Prevalence of Alpha-1 Antitrypsin Deficiency in a Retrospective Cohort of Patients Diagnosed with HCC on Non-Cirrhotic Liver up to 1 year

次要结局

  • Correlation of clinico-biological parameters-including survival (years), sex, BMI, fibrosis stage, mode of diagnosis, number of tumors, tumor size (mm), metastasis, recurrence, and Edmondson score-according to AAT genotype(1 year)

研究者

发起方
University Hospital, Bordeaux
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验